Kai-Cheng Hsu Selected Research

Kai-Cheng Hsu Research Topics

Disease

27	Neoplasms (Cancer) 03/2024 - 01/2014
6	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2018
5	Prostatic Neoplasms (Prostate Cancer) 06/2023 - 07/2014
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 05/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 10/2020
4	Leukemia 11/2021 - 04/2017
3	Genomic Instability 03/2024 - 07/2014
3	Human Influenza (Influenza) 01/2021 - 01/2013
2	Triple Negative Breast Neoplasms 06/2024 - 06/2020
2	Breast Neoplasms (Breast Cancer) 06/2024 - 06/2020
2	Neuroinflammatory Diseases 04/2024 - 11/2020
2	Glioblastoma (Glioblastoma Multiforme) 08/2023 - 05/2021
2	Neoplasm Metastasis (Metastasis) 06/2023 - 01/2018
2	Hypertension (High Blood Pressure) 01/2023 - 01/2022
2	Lassa Fever (Fever, Lassa) 12/2021 - 01/2016
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2021 - 01/2018
2	Squamous Cell Carcinoma of Head and Neck 10/2020 - 09/2019
2	Infections 01/2017 - 11/2016
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2016 - 05/2015
2	Parkinson Disease (Parkinson's Disease) 01/2016 - 01/2016
1	Cognitive Dysfunction 05/2024
1	Retinal Degeneration 04/2024
1	Lung Neoplasms (Lung Cancer) 03/2024
1	Amyloid Plaque 12/2023
1	Down Syndrome (Down's Syndrome) 12/2023
1	Stroke (Strokes) 09/2023
1	Peripheral Arterial Disease 09/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2023
1	Fibrosis (Cirrhosis) 03/2023
1	Hyperlipidemias (Hyperlipidemia) 01/2023
1	Cerebral Hemorrhage 01/2023
1	Atherosclerosis 01/2023
1	COVID-19 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Ischemic Stroke 01/2022
1	ST Elevation Myocardial Infarction 01/2022

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2014
6	Phosphotransferases (Kinase)IBA 06/2024 - 06/2015
5	Histone Deacetylase InhibitorsIBA 06/2021 - 01/2018
4	Histone Deacetylases (Histone Deacetylase)IBA 12/2023 - 12/2020
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2022
3	Neuroprotective AgentsIBA 01/2023 - 01/2016
3	CholesterolIBA 01/2022 - 01/2019
3	EnzymesIBA 12/2021 - 12/2013
3	FlavonoidsIBA 01/2021 - 01/2014
3	Neuraminidase (Sialidase)IBA 01/2017 - 01/2013
2	B7-H1 AntigenIBA 03/2024 - 03/2020
2	CaspasesIBA 07/2023 - 05/2021
2	RNA (Ribonucleic Acid)IBA 06/2023 - 12/2021
2	LipidsIBA 01/2022 - 01/2019
2	Exonucleases (3' 5' Exonuclease)IBA 12/2021 - 01/2016
2	Hydroxamic Acids (Hydroxamic Acid)IBA 12/2021 - 05/2021
2	Matrix Metalloproteinases (MMPs)IBA 11/2021 - 07/2020
2	entinostat (MS 275)IBA 06/2021 - 06/2020
2	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 04/2021 - 06/2020
2	Histone Deacetylase 6IBA 12/2020 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 10/2020 - 06/2020
2	benzamideIBA 06/2020 - 01/2019
2	quinolineIBA 10/2019 - 04/2017
2	Lactulose (Duphalac)FDA LinkGeneric 01/2016 - 05/2015
2	polyglutamineIBA 01/2016 - 05/2015
2	TrehaloseIBA 01/2016 - 05/2015
2	TrehalaseIBA 01/2016 - 05/2015
2	MelibioseIBA 01/2016 - 05/2015
1	N-Methylaspartate (NMDA)IBA 04/2024
1	Antiglaucoma AgentsIBA 04/2024
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 03/2024
1	Doxycycline (Periostat)FDA LinkGeneric 03/2024
1	Gefitinib (Iressa)FDA Link 03/2024
1	Dyrk KinasesIBA 12/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023
1	Monoamine Oxidase (MAO)IBA 08/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2023
1	PhosphatidylserinesIBA 07/2023
1	AndrogensIBA 06/2023
1	CateninsIBA 06/2023
1	Cyclin-Dependent Kinase 8IBA 06/2023
1	RNA Polymerase II (RNA Polymerase B)IBA 06/2023
1	CytokinesIBA 03/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Transfer RNA (tRNA)IBA 01/2023
1	GlutaminaseIBA 10/2022
1	3-hydroxyflavoneIBA 06/2022
1	Serum AlbuminIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	fms-Like Tyrosine Kinase 3IBA 01/2022
1	Pargyline (Pargyline Hydrochloride)FDA Link 12/2021
1	xestoquinoneIBA 11/2021
1	Cysteine (L-Cysteine)FDA Link 11/2021

Therapy/Procedure

12	Therapeutics 03/2024 - 01/2018
2	Radiotherapy 05/2021 - 09/2019
2	Drug Therapy (Chemotherapy) 01/2020 - 04/2017
1	Surgical Amputation (Amputations) 09/2023
1	Castration 06/2023
1	Percutaneous Coronary Intervention 01/2022